OCRA’s dedicated staff members bring passion, expertise, and a collaborative spirit to the fight against ovarian and related gynecologic cancers. Whether spearheading innovative research initiatives or creating engaging support programs, OCRA’s team is devoted to advancing progress and igniting hope. Together, we are committed to improving the lives of patients and their families, ensuring anyone impacted by gynecologic cancer feels understood, empowered, and supported.
Audra Moran
President & CEO
As President & CEO of Ovarian Cancer Research Alliance (OCRA), Audra heads the largest global charity for ovarian and related gynecologic cancer research and advocacy. She directs overall strategy, operations, and fundraising to promote progress and awareness while hastening breakthroughs in diagnostics and treatments with the ultimate goal of finding a cure.
Sarah DeFeo
Chief Program Officer
Sarah DeFeo, OCRA’s Chief Program Officer, joined OCRA in November 2008 and oversees OCRA’s annual grant solicitation and review progress, working closely with the Scientific Advisory Committee. Under her leadership, applications to OCRA’s three research grant programs have quadrupled.
Vice President, Support & Education
Senior Director, Treatment Access and Scientific Education
Senior Director, Social Work Education and Research
Director, Patient Support
Director, Survivors Teaching Students®
Director, Education
Senior Manager, Patient Support
Senior Manager, Programs
Manager, Programs
Steps Counselor
Steps Counselor
Steps Counselor
Jon Zeidman
Chief Development Officer
Jon Zeidman is OCRA’s Chief Development Officer, where he leads the organization’s comprehensive revenue strategy, including major gifts, annual giving, corporate and industry partnerships, foundation relations, special events, and planned giving. As a member of OCRA’s executive team, he helps shape the organization’s strategic direction and long-term growth. Jon also provides executive oversight for the organization’s finance, human resources, and operational functions.
Lydia Smith
Vice President, Operations & Finance
Lydia Smith is OCRA’s Vice President, Operations & Finance. She joined the organization in 2024 and oversees core operational functions, including human resources, information technology, compliance, and organizational infrastructure, as well as executive oversight of financial management. She brings a strategic, systems-focused approach to building efficient and mission-aligned operations that support OCRA’s work.
SEATTLE, WA, July 9, 2026 — Nearly 1,000 runners, walkers, survivors, families, friends, and supporters are expected to gather at Seward Park on Sunday, July 12, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, one of the nation’s longest-running events dedicated to funding ovarian cancer research. Participants of all ages and abilities will transform … Continued
Nearly 500 people have already registered for OCRA’s International Gynecologic Cancer Conference®—the largest conference dedicated to the gynecologic cancer community—taking place on September 16–17. The conference is free, online, and open to all, and will include programming for ovarian, endometrial, cervical, and rare gynecologic cancers. For the first time, each of these diseases will have a dedicated Ask the Experts session. Learn … Continued
On June 1–2, the Ovarian Cancer Observatory—part of OCRA’s broader investment in research initiatives—convened its first in-person Forum in Vancouver. Roughly 50 of the field’s brightest clinicians, pathologists, and epidemiologists gathered for what became, in essence, a two-day think tank on preventing ovarian cancer. The Observatory is funded through a grant from OCRA and was … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
